Not surprisingly, dysregulation of the Eph-ephrin system is exploited to support malignant cell growth, making the Eph-ephrin system a sought-after target for cancer therapy (reviewed by [4,5,6,7]). This evidence concerns the gene EPHA1 and cancer.